Insider Transactions Reported by 10 Insiders of Apogee Therapeutics, Inc.

Symbol
APGE on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apogee Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MICHAEL THOMAS HENDERSON Chief Executive Officer, Director $99,960,380 -$8,300,663 -7.7% 14 Jan 2026
Fairmount Funds Management LLC Director $30,510,804 -$133,525,000 -81% 22 Jan 2026
Carl Dambkowski Chief Medical Officer $17,014,591 -$4,261,125 -20% 07 Jan 2026
Nimish P. Shah Director $14,999,936 +$14,999,936 10 Oct 2025
Jane Henderson Chief Financial Officer $14,829,680 -$1,136,646 -7.1% 02 Jan 2026
Mark C. McKenna Director $997,000 17 Jun 2025
Lisa Bollinger Director 17 Jun 2025
WILLIAM A. JONES JR Director 17 Jun 2025
Jennifer A. Fox Director 17 Jun 2025
Andrew Gottesdiener Director 17 Jun 2025

Recent Insider Transactions by Companies or Individuals for Apogee Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.